Oxford BioMedica plc  

(Public, LON:OXB)   Watch this stock  
Find more results for OXB
-0.39 (-5.45%)
Feb 8 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 6.75 - 7.47
52 week 5.39 - 13.38
Open 7.01
Vol / Avg. 1.11M/2.45M
Mkt cap 174.28M*
P/E     -
Div/yield     -
EPS 0.00*
Shares 2.57B
Beta     -
Inst. own     -
May 6, 2016
Oxford BioMedica PLC Annual Shareholders Meeting (Estimated) - 10:00AM GMT+1 - Add to calendar

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -139.78% -63.60%
Operating margin -188.77% -77.93%
EBITD margin - -69.86%
Return on average assets -32.48% -36.51%
Return on average equity -60.64% -54.24%
Employees 192 -
CDP Score - -


Windrush Court,Transport Way
United Kingdom - Map
+44-1865-783000 (Phone)
+44-1865-783001 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Oxford BioMedica plc is a United Kingdom-based gene and cell therapy research and development business. The Company is lentiviral vector and cell therapy research, development and manufacture. It provides a platform of technologies and capabilities with which it designs, develops and manufactures gene and cell-based medicines. The Company's clinical pipeline is targeting Parkinson's disease, selected cancers and a number of serious eye diseases. The Company has four clinical programs in active development and two other products, including EncorStat and OXB-102, being readied for Phase I/II. EncorStat is being studied for the prevention of corneal graft rejection. OXB-102 is being studied to target Parkinson's disease.

Officers and directors

John Dawson Chief Executive Officer, Executive Director
Age: 55
Tim Watts Chief Financial Officer, Company Secretary, Executive Director
Age: 57
Paul Blake M.D. Executive Director, Chief Development Officer
Age: 66
Peter Nolan Executive Director, Chief Business Officer
Age: 62
Nicholas Rodgers Non-Executive Director
Age: 56
Andrew J. Heath M.D., Ph.D. Non-Executive Deputy Chairman of the Board, Senior Independent Director
Age: 66
Martin Diggle Non-Executive Director
Age: 52